The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2023Mobility Matters: A Mobilise-D Extension Study
Study Rationale: Mobility, the ability to physically move around, is vitally important and key to an individual’s independence. Although loss of mobility is a key feature in Parkinson’s disease (PD)...
-
Research Grant, 2023Ensuring Diversity and Equity in Parkinson’s Disease Research and Care
Study Rationale: Parkinson’s disease (PD) is one of the most common neurodegenerative disorders across the world. PD has a negative impact on a person’s mobility and their ability to carry out...
-
Research Grant, 2023Evaluating a Gene Therapy that Restores Mitochondrial Function as a Treatment for Parkinson’s Disease
Study Rationale: Currently, all treatments for Parkinson’s disease (PD) aim to improve symptoms by restoring or maintaining the levels of dopamine in the brain. No treatment on the market slows or...
-
Research Grant, 2023Validation of Gap Junction Proteins as a New Therapeutic Target for Impeding the Cell-to-cell Spread of Alpha-synuclein in Parkinson’s Disease and Related Synucleinopathies
Study Rationale:The gap junctions that directly connect one cell with its neighbor have recently been implicated in the transfer of alpha-synuclein pathology associated with Parkinson’s disease (PD)...
-
Spring 2022 RFP: Proof-of-Concept Testing of PD Therapeutics, 2022Preclinical Models and Therapies for the Gastrointestinal Symptoms of Parkinson’s Disease
Study Rationale: In addition to the well-recognized movement abnormalities associated with Parkinson’s disease (PD), gastrointestinal symptoms such as constipation, leaky gut and inflammation are also...
-
Research Grant, 2022Evaluation of Assessments Made by Digital Health Technology
Study Rationale: The development of drugs that can slow or halt the progression of Parkinson’s disease (PD) can be expensive and take a long time. Although there are many promising new therapeutics in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.